What does CJC 1295 no DAC do? It's a short-acting GHRH analog that signals the pituitary to release growth hormone. Learn how it works, dosing, and safety.
CJC-1295 no DAC is a synthetic peptide that acts as a growth hormone-releasing hormone (GHRH) analog. It binds to GHRH receptors in the pituitary gland and triggers the release of growth hormone (GH) in short pulses. Because it lacks the Drug Affinity Complex (DAC), its half-life is only about 30 minutes, so its effect on GH release is brief rather than sustained.
How CJC-1295 No DAC Works in the Body
The pituitary releases GH in pulses, mostly during deep sleep and after hard exercise. CJC-1295 no DAC mimics the body's own GHRH signal, telling the pituitary to produce more of those pulses.
Key points about its mechanism:
- It binds GHRH receptors on somatotroph cells in the anterior pituitary.
- It increases both the frequency and the amplitude of GH pulses.
- It does not act on ghrelin receptors, so hunger and cortisol signaling are less affected than with GHRP-6 or GHRP-2.
- Its short half-life means GH rises quickly and drifts back toward baseline within a few hours.
Because GH release stays pulsatile, the no-DAC form is often described in research literature as a more physiological option than long-acting GHRH analogs.
CJC-1295 No DAC vs CJC-1295 With DAC
Both peptides share the same core 29-amino-acid sequence, but they behave very differently once injected. The DAC version binds to albumin in the blood, which stretches its half-life from minutes to days.
| Feature | CJC-1295 No DAC (Mod GRF 1-29) | CJC-1295 With DAC |
|---|---|---|
| Half-life | Roughly 30 minutes | About 6–8 days |
| GH release pattern | Short, pulsatile bursts | Steady elevation of baseline GH and IGF-1 |
| Albumin binding | Minimal | Strong |
| Common research focus | Pulsatile GH studies, stacking with ghrelin mimetics | Long-acting IGF-1 elevation |
| Typical stacking partners | Ipamorelin, GHRP-2, GHRP-6 | Rarely stacked |
The longer-acting form also tends to produce more water retention and a flatter GH curve, which is why pulsatile protocols usually stick with the no-DAC version.
How It Compares to Sermorelin and Ipamorelin
Researchers often ask about cjc-1295 no dac vs sermorelin because both are GHRH analogs. Sermorelin is the natural 1-29 fragment of GHRH, while CJC-1295 no DAC is a modified version with four amino acid substitutions that resist enzyme breakdown.
| Peptide | Class | Half-life | Main effect |
|---|---|---|---|
| CJC-1295 no DAC | GHRH analog | ~30 minutes | Increases GH pulse amplitude |
| Sermorelin | GHRH analog | ~10–20 minutes | Increases GH pulse, shorter duration |
| Ipamorelin | Ghrelin mimetic (GHS-R agonist) | ~2 hours | Increases GH pulse with less appetite effect |
| Tesamorelin | GHRH analog | ~30 minutes | FDA-approved for excess abdominal fat in specific conditions |
People researching what is cjc-1295 ipamorelin used for are usually looking at a GHRH analog paired with a ghrelin mimetic. The two hit different receptors, which is why they are studied together for a larger combined GH pulse.
Typical Dosing and Injection Frequency in Research
CJC-1295 no DAC is not approved for human use, so no official dosing standard exists. Published protocols and community cjc-1295 no dac dosage chart references typically land between 100 mcg and 300 mcg per injection, one to three times daily.
Questions about how often do you inject cjc-1295 ipamorelin usually get the same answer: injections are timed to match natural GH pulses, most often before bed.
- Timing: usually at night to align with the largest natural GH pulse.
- Frequency: once daily is most common; some protocols split into two or three doses.
- Cycle length: often studied in 8–12 week blocks with breaks in between.
- Storage: lyophilized powder stays refrigerated; reconstituted peptide is used within a few weeks.
These numbers come from anecdotal reports and small studies, not from large controlled human trials of CJC-1295 no DAC.
Does CJC-1295 Work? What the Evidence Shows
The honest answer to does cjc-1295 work depends on what you mean by "work." CJC-1295 no DAC reliably raises GH in short-term research settings, and the DAC version has been shown to raise IGF-1 in human studies.
- GH and IGF-1 increase measurably after injection in published research.
- Effects on body composition, recovery, and sleep are mostly anecdotal.
- No large, long-term human trial shows fat loss, muscle gain, or anti-aging outcomes for the no-DAC form.
- Results depend on dose, timing, sleep, diet, and whether the peptide is combined with a ghrelin mimetic.
Raising growth hormone is not the same as improving health outcomes. More GH does not automatically mean more muscle or less fat.
Safety, Side Effects, and Legal Status
CJC-1295 no DAC is a research chemical. It is not FDA-approved for human use in the United States, and it is not a dietary supplement. Online sellers operate in a gray area, and product purity varies widely between vendors.
Reported side effects in anecdotal accounts include:
- Injection site irritation, redness, or swelling
- Headache, flushing, or dizziness shortly after injecting
- Water retention or joint discomfort
- Increased appetite when stacked with GHRP-6 or GHRP-2
- Possible effects on blood sugar and insulin sensitivity with extended use
Anyone with a history of cancer, pituitary disease, diabetes, or hormonal conditions should speak with a healthcare professional before considering any GH-related peptide. Self-dosing with unregulated peptides carries real risk, including contamination and dosing errors.
Bottom Line
CJC-1295 no DAC is a short-acting GHRH analog that prompts the pituitary to release growth hormone in pulses. It is most often studied alongside ipamorelin or another ghrelin mimetic, and its effects fade within hours because it lacks the DAC that extends half-life.
Evidence for benefits beyond a temporary rise in GH and IGF-1 is limited. Anyone weighing use should focus on legal status, product quality, and medical guidance rather than marketing claims.
Frequently Asked Questions
Does CJC-1295 no DAC really raise growth hormone?
Yes. CJC-1295 no DAC binds GHRH receptors in the pituitary and increases both the frequency and size of growth hormone pulses. The rise is short-lived, typically fading within a few hours because the peptide's half-life is only about 30 minutes.
How is CJC-1295 no DAC different from CJC-1295 with DAC?
CJC-1295 with DAC binds to albumin in the blood and lasts roughly 6–8 days, producing a steady rise in GH and IGF-1. CJC-1295 no DAC lacks that modification, so its half-life is closer to 30 minutes and it produces brief, pulsatile GH release instead.
Is CJC-1295 no DAC legal and safe in the US?
CJC-1295 no DAC is not FDA-approved for human use and is sold only as a research chemical in the United States. It is not legal to market it as a supplement or drug, and reported side effects include injection site irritation, headache, water retention, and possible blood sugar changes.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.